IRIS
RESTEGHINI, CARLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 642
NA - Nord America 482
SA - Sud America 203
EU - Europa 112
AF - Africa 16
Totale 1.455
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 461
SG - Singapore 426
BR - Brasile 189
CN - Cina 139
IT - Italia 30
DE - Germania 26
HK - Hong Kong 21
GB - Regno Unito 18
IN - India 17
CA - Canada 11
BD - Bangladesh 9
ZA - Sudafrica 9
RU - Federazione Russa 7
AR - Argentina 6
PL - Polonia 6
FR - Francia 5
IQ - Iraq 5
MX - Messico 5
IE - Irlanda 4
KE - Kenya 4
PK - Pakistan 4
SA - Arabia Saudita 3
SE - Svezia 3
TR - Turchia 3
UA - Ucraina 3
UZ - Uzbekistan 3
VE - Venezuela 3
VN - Vietnam 3
AE - Emirati Arabi Uniti 2
CO - Colombia 2
EC - Ecuador 2
ES - Italia 2
KZ - Kazakistan 2
NP - Nepal 2
AL - Albania 1
AM - Armenia 1
AT - Austria 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BE - Belgio 1
BH - Bahrain 1
BM - Bermuda 1
BO - Bolivia 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
EG - Egitto 1
ET - Etiopia 1
FI - Finlandia 1
GT - Guatemala 1
IL - Israele 1
LT - Lituania 1
MA - Marocco 1
NI - Nicaragua 1
PA - Panama 1
Totale 1.455
Salva come PNG Salva come JPEG
Città #
Singapore 221
The Dalles 180
Shanghai 135
Seattle 24
Boardman 19
Hong Kong 17
Naples 14
Ashburn 12
Los Angeles 12
São Paulo 12
Düsseldorf 11
Brooklyn 7
Milan 7
Santa Clara 7
Rio de Janeiro 6
Chicago 5
Munich 5
New York 5
Portsmouth 5
San Francisco 5
Warsaw 5
Brasília 4
Campinas 4
Johannesburg 4
Montreal 4
Nairobi 4
Bengaluru 3
Buffalo 3
Caruaru 3
Conselheiro Lafaiete 3
Dublin 3
Goiânia 3
London 3
Mexico City 3
Stockholm 3
Tashkent 3
Almaty 2
Atlanta 2
Belo Horizonte 2
Cachoeirinha 2
Camaragibe 2
Cape Town 2
Cariacica 2
Chennai 2
Cincinnati 2
Cotia 2
Curitiba 2
Duque de Caxias 2
Genoa 2
Guarulhos 2
Ho Chi Minh City 2
Hyderabad 2
Istanbul 2
Jaú 2
Joinville 2
Kathmandu 2
Kowloon City 2
Lahore 2
Mogi das Cruzes 2
Monza 2
Natal 2
Palmdale 2
Paris 2
Petrolina 2
Phoenix 2
Pretoria 2
Riyadh 2
Secaucus 2
St Petersburg 2
Sulaymaniyah 2
São Vicente 2
Tatuí 2
Topeka 2
Uberlândia 2
Vitória de Santo Antão 2
Abaetetuba 1
Abu Dhabi 1
Acopiara 1
Addis Ababa 1
Aparecida de Goiânia 1
Aracaju 1
Araci 1
Araxá 1
Barra Mansa 1
Bauru 1
Bedford 1
Bela Vista de Goiás 1
Belleville 1
Belo Jardim 1
Belém 1
Bhiwadi 1
Birigui 1
Blue Island 1
Blumenau 1
Brantford 1
Brasiléia 1
Braço do Norte 1
Bridgetown 1
Brno 1
Brumadinho 1
Totale 867
Salva come PNG Salva come JPEG
Nome #
Precision medicine in Salivary Gland Carcinoma: Insights from breast and prostate cancer 27
BRAF V600E-mutated anaplastic thyroid carcinoma (ATC) and treatment with BRAF-inhibitors: Real-world data from a single-institution, still far from the cure 26
BD4QoL: A multicenter randomized trial for monitoring quality of life (QoL) by intelligent tools in head and neck cancer (HNC) survivors after curative treatment 26
A pilot study of a smartphone-based monitoring intervention on head and neck cancer patients undergoing concurrent chemo-radiotherapy 25
A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact 25
Baseline neutrophil-to-lymphocyte ratio is associated with outcome in recurrent/metastatic head and neck squamous cell cancer patients treated with platinum and cetuximab in first line setting 24
A multicenter randomized trial for quality of life evaluation by non-invasive intelligent tools during post-curative treatment follow-up for head and neck cancer: Clinical study protocol 24
An added value to Multidisciplinary Team: does a Tutor help to manage head and neck cancer patients? 24
A retrospective cohort study of PD-L1 expression in recurrent and/or metastatic squamous cell carcinoma of the head and neck (SUPREME-HN). 23
Health care-associated infections (HAIs) in head and neck carcinoma (HNC) patients treated with chemotherapy (CT) and/or radiotherapy (RT) 23
A retrospective multicenter Italian analysis of the effect of longer vismodegib intake in 68 basal cell carcinoma patients who achieved clinical complete remission 22
Anticipation of the Impact of Human Papillomavirus on Clinical Decision Making for the Head and Neck Cancer Patient 21
Age related toxicity and outcome in oropharyngeal and nasoparyngeal cancer patients 21
Immunotherapy followed by cetuximab in locally advanced/metastatic (LA/M) cutaneous squamous cell carcinomas (cSCC): The I-TACKLE trial 21
Big Data in Head and Neck Cancer 21
The association of cemiplimab plus sonidegib for synchronous cutaneous squamous cell carcinoma and basal cell carcinoma of the head and neck: Two case reports 21
Bone metastases from head and neck malignancies: Prognostic factors and skeletal-related events 21
Treatment Options for Recurrent Anterior Skull Base Tumors 21
A single institution twenty-year experience of recurrent or metastatic epithelial non glandular sinonasal cancer 21
Abiraterone Acetate in Patients With Castration-Resistant, Androgen Receptor-Expressing Salivary Gland Cancer: A Phase II Trial 20
A multicentre retrospective analysis of recurrent/metastatic (RM) nasopharyngeal cancer (NPC) from non-endemic areas: Results in the pre-immunotherapy era 20
The SINTART 1 study: A phase II trial of induction chemotherapy (IC), surgery, photon-, proton-and carbon ion-based radiotherapy (RT) integration in locally advanced operable sinonasal epithelial tumors patients (pts) 20
Does a multidisciplinary team approach in a tertiary referral centre impact on the initial management of head and neck cancer? 19
Do not throw the baby out with the bathwater: SELECT a personalized, de-escalated lenvatinib schedule allows response in locally advanced DTC while controlling major drug-related bleeding 19
The SINTART 1 study. A phase II non-randomised controlled trial of induction chemotherapy, surgery, photon-, proton- and carbon ion-based radiotherapy integration in patients with locally advanced resectable sinonasal tumours 19
Fentanyl pectin nasal spray as treatment for incident predictable breakthrough pain (BTP) in oral mucositis induced by chemoradiotherapy in head and neck cancer 18
RetroSpective cohort stUdy of PD-L1 expression in REcurrent and/or MEtastatic (R/M) squamous cell carcinoma of the head and neck (SUPREME-HN) 18
A phase II trial of dacomitinib in locally advanced unresectable or metastatic skin squamous cell carcinoma 18
Temporal course and predictive factors of analgesic opioid requirement for chemoradiation-induced oral mucositis in oropharyngeal cancer 17
A phase II trial of induction chemotherapy (IC), photon-, proton- and carbon ion-based radiotherapy (RT) integration in locally advanced inoperable sinonasal epithelial tumors patients (pts) 17
The SINTART 2 Study. A phase II non-randomised controlled trial of induction chemotherapy, photon-, proton- and carbon-ion-based radiotherapy integration in patients with locally advanced unresectable sinonasal tumours 17
Efficacy and safety of single agent pan-HER inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer (sSCC). 17
Management of tyrosine kinase inhibitors (TKI) side effects in differentiated and medullary thyroid cancer patients 16
Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma 16
Transcriptomic and tumor microenvironment landscape of EBV related nasopharyngeal carcinoma in endemic and non-endemic areas 16
Genomics in non-adenoid cystic group of salivary gland cancers: one or more druggable entities? 16
Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy 16
Transcriptomics and Epigenomics in head and neck cancer: available repositories and molecular signatures 16
HER2 status in recurrent/metastatic androgen receptor overexpressing salivary gland carcinoma patients 16
Activity of platinum and cetuximab in cutaneous squamous cell cancer not amenable to curative treatment 16
Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer 16
Circulating pre-treatment Epstein-Barr virus DNA as prognostic factor in locally-advanced nasopharyngeal cancer in a nonendemic area 16
Druggable molecular targets in skin adnexal malignancies 16
Radiomics-based prediction of response to multikinase inhibitors in radioiodine-refractory differentiated thyroid cancer patients 16
The Evolving Role of Systemic Therapy in the Primary Treatment of Sinonasal Cancer. 16
Hyperprogressive disease (HPD) in head and neck squamous cell carcinoma (HNSCC) patients treated with immune checkpoint inhibitors (ICI) 16
Phase 2 study on axitinib in recurrent/metastatic salivary gland cancer of upper aerodigestive tract 15
RetroSpective cohort stUdy of PD-L1 expression in REcurrent and/or MEtastatic squamous cell carcinoma of the head and neck (SUPREME-HN) 15
Locally advanced epithelial sinonasal tumors: The impact of multimodal approach 15
Monitoring patients with head and neck cancer for flu-like symptoms during the COVID-19 pandemic 15
RANK expression in EBV associated nasopharyngeal cancer metastasis in non-endemic setting: a possible immunologic pathway to be targeted? 15
Prognostic nomogram in patients with metastatic adenoid cystic carcinoma of the salivary glands 15
Retrospective analysis of baseline clinical factors associated to CDDP-nephrotoxicity in locally advanced head and neck cancer (LAHNC) patients 15
PD-L1 Expression in Unresectable Locally Advanced or Metastatic Skin Squamous Cell Carcinoma Treated with Anti-Epidermal Growth Factor Receptor Agents 15
Mutational profile of epithelial, non-glandular sinonasal cancers into 2 prospective clinical trials 15
Patients with adenoid cystic carcinomas of the salivary glands treated with lenvatinib: Activity and quality of life 14
Phase II trial with axitinib in recurrent and/or metastatic salivary gland cancers of the upper aerodigestive tract 14
Mining of self-organizing map gene-expression portraits reveals prognostic stratification of HPV-positive head and neck squamous cell carcinoma 14
Surveillance of Patients with Head and Neck Cancer with an Intensive Clinical and Radiologic Follow-up 14
Head and neck cancers survival in Europe, Taiwan, and Japan: results from RARECAREnet Asia based on a privacy-preserving federated infrastructure 14
Role of induction chemotherapy in the multimodal management of locally advanced epithelial sinonasal cancer: a single center experience 14
Low etiologic fraction for human papillomavirus in larynx squamous cell carcinoma 14
Response of the Istituto Nazionale Tumori of Milan Head & Neck Cancer Unit to the COVID-19 outbreak. 13
The Interplay between Age and Viral Status in EBV-Related Nasopharyngeal and HPV-Related Oropharyngeal Carcinoma Patients 13
Clinical prognostic factors in patients with recurrent or metastatic carcinoma of the head and neck treated with immune checkpoints therapies. 13
Neoplasie testa collo 13
Prognostic role of PIK3CA and TP53 in human papillomavirus–negative oropharyngeal cancers 13
Refining Tumor Treatment in Sinonasal Cancer Using Delta Radiomics of Multi-Parametric MRI after the First Cycle of Induction Chemotherapy 13
Sinonasal non-glandular cancers relapsing after multimodal treatments 13
Pre-treatment risk factors to predict early cisplatin-related nephrotoxicity in locally advanced head and neck cancer patients treated with chemoradiation: A single Institution experience 13
Prognostic Value of Metabolic Parameters by 18 F-FDG PET/CT in Nasopharyngeal Cancer (NPC) in Non-Endemic Area 13
Management of loco-regionally advanced squamous laryngeal cancer in elderly patients 13
Could the extreme conformality achieved with proton therapy in paranasal sinuses cancers accidentally results in a high rate of leptomeningeal progression? 12
Retreatment with Vismodegib is active in progressive advanced Basal Cell Carcinoma: first report from a single-Institution experience 12
Circulating pretreatment Epstein Barr Virus DNA quantification as a prognostic factor in nasopharyngeal cancer patients in a non endemic area 12
SUPREME-HN: a retrospective biomarker study assessing the prognostic value of PD-L1 expression in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck 12
Subsite-dependent prognostic impact of age in patients with nasopharyngeal and oropharyngeal cancer 12
Survival differences between EU and Asia for head and neck cancer: Results of the RARECAREnet-Asia collaboration 12
Role of induction chemotherapy in the multimodal management of locally advanced epithelial sinonasal cancer 12
Immunotherapy in nonendemic nasopharyngeal carcinoma: Real-world data from two nonendemic regions 12
Phase II study on lenvatinib (LEN) in recurrent and/or metastatic (R/M) adenoid cystic carcinomas (ACC) of the salivary glands (SG) of the upper aereodigestive tract (NCT02860936) 11
Late toxicities burden in patients with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib 11
RANK expression in EBV positive nasopharyngeal carcinoma metastasis: A ready-to-treat target? 11
Hedgehog Inhibitors Beyond Clinical Complete Response in Basal Cell Carcinoma: Should I Stop or Should I Go? 11
Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies 11
Radiomics-based prediction of response to induction chemotherapy in sinonasal cancer 11
Tumor molecular landscape of Epstein-Barr virus (EBV) related nasopharyngeal carcinoma in EBV-endemic and non-endemic areas: Implications for improving treatment modalities 11
Nasopharyngeal cancer in non-endemic areas: Impact of treatment intensity within a large retrospective multicentre cohort 11
Health care-associated infections in patients with head and neck cancer treated with chemotherapy and/or radiotherapy 11
Prolonged response using gefitinib followed by sirolimus for advanced cutaneous squamous cell carcinoma 11
Local therapies for liver metastases of rare head and neck cancers: A monoinstitutional case series 11
Prognostic role of primary tumor, nodal neck, and retropharyngeal GTVs for unresectable sinonasal cancers treated with IMRT and chemotherapy 10
Outcome of recurrent and metastatic head and neck squamous cell cancer patients after first line platinum and cetuximab therapy 10
Relevance of apparent diffusion coefficient features for a radiomics-based prediction of response to induction chemotherapy in sinonasal cancer 10
Systemic therapy in metastatic salivary gland carcinomas: A pathology-driven paradigm? 9
Nausea and vomiting during the first 3 intercycle periods in chemo-naive cancer patients receiving moderately/highly emetogenic therapy 9
Multidisciplinary management of pregnancy-associated and early post-partum head and neck cancer patients 9
Lenvatinib in Relapsed/Metastatic Adenoid Cystic Carcinoma: Real-World Data From 17 Italian Centers 8
Sinonasal malignancy: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up 5
Treatment-related mortality in head and neck cancer patients receiving chemotherapy and radiation: results of a meta-analysis of published trials 4
Totale 1.554
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.837
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.837
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024344 0 0 0 0 0 0 0 47 52 45 83 117
2024/20251.091 40 5 3 7 7 107 49 66 188 270 176 173
2025/2026123 123 0 0 0 0 0 0 0 0 0 0 0
Totale 1.558